This site is intended for healthcare professionals

T-cells could play a vital role in the hair growth

Time : 27th of June 2022 02:59:17 PM Physician/Medicine,Dermatology

The regulatory T-cells interact with the skin cells using glucocorticoids as a messenger for generating new hair follicles, as per a study. Glucocorticoids induce TGF-beta3 production in regulatory T-cells, resulting in the activation of stem cells to differentiate into new follicles promoting hair growth irrespective of T-cells' ability to regulate immune balance.
  Salk Institute for Biological Studies


An approach to diagnosing lupus with cutaneous manifestations

Time : 27th of June 2022 01:42:03 PM Physician/Medicine,Dermatology

An expert from Yale University emphasised that counting the number of cutaneous eruptions can be helpful while making a Systemic lupus erythematosus diagnosis. There are less recognised signs for systemic lupus, including the TN-like SLE. People also report other symptoms such as photosensitivity, burning sensation, atopic dermatitis, tender nodules and eruptions.
  Dermatology Times


No difference noticed between tretinoin therapy and tretinoin precursors

Time : 27th of June 2022 12:57:34 PM Physician/Medicine,Pharma News,Dermatology

There was no difference in the treatment efficacy between topical tretinoin precursors (TTP) and tretinoin retinoic acid (RA), as per a trial. However, patients treated with RA more often reported erythema during the treatment course than those in the TTP group. The patients on TTP showed a decrease in the score of Griffiths photodamage by week 24 than those in the RA group.
  Healio


How to approach genital skin complaints in men and women?

Time : 23rd of June 2022 02:04:55 PM Dermatology

Making the patient more comfortable, especially when discussing genital dermatology complaints and asking them about their prior medication use for the condition is beneficial. Also, a stepwise screening of the total genital area helps diagnose the disease. The most common dermatological conditions related to genitals are irritant contact dermatitis, psoriasis, and eczema.
  Dermatology Times


Atopic dermatitis could be rarely triggered by food in kids with food allergies

Time : 22nd of June 2022 01:32:57 PM Paediatrics,Nutrition & Fitness,Dermatology

Only 3% of kids with food allergies had food-triggered atopic dermatitis (AD), as per a study. Also, food-triggered AD occurred in 2%, 6%, and 4% of the patients with mild, moderate and severe AD, respectively. About 4% of the patients with IgE-mediated food allergy to one food had food-triggered AD for other food. The common allergies for food-triggered AD are eggs and peanuts.
  Healio


Can ultraviolet nail salon lamps cause skin cancer?

Time : 20th of June 2022 03:19:37 PM Physician/Medicine,Oncology,Entertainment,Dermatology

Nail salons use special lamps to set gel manicures and dry polishes. These lamps emit ultraviolet rays, which cause skin cancer and premature skin ageing. However, the risk of developing skin cancers from manicures can be minor, as per researchers. To be on the safe side, customers are recommended to wear protective gloves or apply sunscreen to decrease the risk of skin cancer.
  Twitter @ClevelandClinic


FDA approves Olumiant for the treatment of alopecia areata

Time : 16th of June 2022 09:31:09 AM Physician/Medicine,Pharma News,Dermatology

Olumiant (baricitinib) is the first systemic treatment to receive approval in adults with severe alopecia areata. Patients who received Olumiant 2 or 4 mg daily achieved nearly 80% of the scalp hair coverage at 36 weeks, as per two trials. Olumiant is not advised to use in combination with cyclosporines, biological immunomodulators, or other JAK inhibitors.
  FDA


FDA warns against the use of OTC products to remove moles or skin spots

Time : 15th of June 2022 01:00:40 PM Pharma News,Dermatology

The US FDA advises consumers to avoid over-the-counter drugs for treating seborrheic keratoses, skin tags or moles due to their potentially harmful side effects and serious risks. Also, the agency received reports regarding the development of infections and permanent skin injuries in people after using the products that are marketed for removing skin tags or moles.
  FDA


Adjunctive RCM use for suspect lesions could reduce unnecessary skin excision

Time : 10th of June 2022 03:25:54 PM Dermatology

Adjunctive reflectance confocal microscopy (RCM) use was associated with a higher positive predictive value and lower benign to malignant ratio, as per a study. Also, RCM use was linked to a 43.4% decrease in the number of lesions needed to excise and identification of invasive melanomas. But 15 lesions had delayed melanoma diagnosis as they were thinner than 0.5 mm.


  Twitter @JAMADerm


FDA approves dupilumab for treating atopic dermatitis in children

Time : 9th of June 2022 09:07:05 AM Pharma News,Paediatrics,Dermatology

FDA approved Dupixent (dupilumab) as the first biologic medicine to treat moderate to severe atopic dermatitis in children aged 6 months to 5 years whose clinical condition is not adequately controlled by topical therapies. Children treated with Dupixent in combination with topical corticosteroids achieved clearer skin and reduced itching in a Phase III trial.


  Global News Wire